Related Experiment Video
Updated: Nov 4, 2025

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria
Bingqing Yang1, Dan Fang1, Qingyan Lv1,2,3
1College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Abstract:
The emergence and rapid spread of antibiotic resistance in pathogenic bacteria constitute a global threat for public health. Despite ongoing efforts to confront this crisis, the pace of finding new potent antimicrobials is far slower than the evolution of drug resistance. The abuse of broad-spectrum antibiotics not only accelerates the formation of resistance but also imposes a burden on the intestinal microbiota, which acts a critical role in human homeostasis. As such, innovative therapeutic strategies with precision are pressingly warranted and highly anticipated. Recently, target therapies have achieved some breakthroughs by the aid of modern technology. In this review, we provide an insightful illustration of current and future medical targeted strategies, including narrow-spectrum agents, engineered probiotics, nanotechnology, phage therapy, and CRISPR-Cas9 technology. We discuss the recent advances and potential hurdles of these strategies. Meanwhile, the possibilities to mitigate the spread of resistance in these approaches are also mentioned. Altogether, a better understanding of the advantages, disadvantages, and mechanisms of action of these targeted therapies will be conducive to broadening our horizons and optimizing the existing antibacterial approaches.
Insights
Antibiotic resistance is a growing global threat. This review explores precision-targeted therapies like narrow-spectrum agents, engineered probiotics, nanotechnology, phage therapy, and CRISPR-Cas9 to combat resistant bacteria.
Area of Science:
- Microbiology and Infectious Diseases
- Biotechnology
- Pharmacology
Background:
- Antibiotic resistance in pathogenic bacteria is a critical global public health issue.
- The development of new antimicrobials lags behind the evolution of resistance.
- Broad-spectrum antibiotic overuse accelerates resistance and harms the gut microbiota.
Purpose of the Study:
- To review current and future precision-targeted therapeutic strategies against antibiotic-resistant bacteria.
- To discuss advances, challenges, and resistance mitigation potential of these strategies.
- To provide insights into optimizing antibacterial approaches through understanding targeted therapies.
Main Methods:
- Review of recent scientific literature on targeted antimicrobial strategies.
- Analysis of narrow-spectrum agents, engineered probiotics, nanotechnology, phage therapy, and CRISPR-Cas9.
- Discussion of mechanisms of action, advantages, and disadvantages.
Main Results:
- Targeted therapies show promise in combating antibiotic resistance.
- Narrow-spectrum agents, engineered probiotics, nanotechnology, phage therapy, and CRISPR-Cas9 are key innovative strategies.
- These approaches offer potential for precision treatment and mitigation of resistance spread.
Conclusions:
- A comprehensive understanding of targeted therapies is essential for developing effective solutions.
- Optimizing existing antibacterial approaches requires evaluating the pros and cons of novel strategies.
- Precision-targeted therapies represent a crucial frontier in the fight against antibiotic resistance.
Related Concept Videos
Biological Methods for Microbial Control
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Microorganisms in Medicine and Therapeutics
Lytic Cycle of Bacteriophages

